Last reviewed · How we verify
Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome (sICASBLM)
sICASBLM is a prospective controlled trial, to asses the impact of improving blood lipid management on clinical outcome of moderate to severe symptomatic intracranial atherosclerotic stenosis patients (LDL-C\>1.8mmol/L) without endovascular therapy.
Details
| Lead sponsor | Nanjing First Hospital, Nanjing Medical University |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 180 |
| Start date | Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri May 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Intracranial Artery Stenosis
Interventions
- PCSK9 inhibitor
Countries
China